Abstract: Methods and compositions using an inhibitor of EGFR signaling for prevention or an inhibitor of EGFR signaling and a nucleic acid molecule encoding an atonal-associated factor for treatment of hearing loss are described.
Type:
Application
Filed:
April 30, 2018
Publication date:
March 26, 2020
Applicant:
ST. JUDE CHILDREN'S RESEARCH HOSPITALEINDHOVEN